https://www.selleckchem.com/pr....oducts/recilisib.htm
001). The total cost was significantly higher for patients in group C in comparison with those in groups A and B (p less then 0.001). Compared with patients in groups A and B, there was statistically significant difference in the length of hospital stay for patients in group C (p less then 0.001). CONCLUSİONS Single-stage ERCP plus LC is a safe and feasible strategy for the management of cholelithiasis and choledocholithiasis, offering advantages of cost, shorter hospital stay, and total anesthesia time. The major advantage of ERCP an